Background: In the liver, bone morphogenetic protein 6 (BMP-6) maintains balanced iron metabolism. However, the mechanism that underlies greater BMP-6 expression in hepatocellular carcinoma (HCC) tissue than adjacent non-cancerous tissue is unclear. This study sought to investigate the epigenetic mechanisms of BMP-6 expression by analysing the relationship between the DNA methylation status of BMP-6 and the expression of BMP-6.
Methods: Methylation-specific polymerase chain reaction (PCR), bisulphite sequencing PCR, the MethyLight assay, and quantitative real-time PCR were performed to examine BMP-6 methylation and mRNA expression levels. Immunohistochemistry (IHC) was performed on tissue arrays to evaluate the BMP-6 protein level.
Results: BMP-6 mRNA expression was approximately 84.09% lower in HCC tissues than in adjacent non-cancerous tissues, and this low level of expression was associated with a poor prognosis. Moreover, the hypermethylation observed in HCC cell lines and HCC tissues was correlated with the BMP-6 mRNA expression level, and this correlation was validated following treatment with 5-aza-CdR, a demethylation agent. In addition, BMP-6 DNA methylation was upregulated by 68.42% in 114 clinical HCC tissue samples compared to adjacent normal tissues, whereas the BMP-6 staining intensity was downregulated by 77.03% in 75 clinical HCC tissue samples in comparison to adjacent normal tissues. Furthermore, elevated expression of BMP-6 in HCC cell lines inhibited cell colony formation.
Conclusions: Our results suggest that BMP-6 CpG island hypermethylation leads to decreased BMP-6 expression in HCC tissues.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907571 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087994 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
[Corrigendum] BMP‑6 inhibits the metastasis of MDA‑MB‑231 breast cancer cells by regulating MMP‑1 expression.
Oncol Rep
December 2024
College of Psychology, North China university of Science and Technology, Tangshan, Hebei 063000, P.R. China.
Article Synopsis
- A reader pointed out that two data panels in the authors' publication appeared to be too similar and possibly incorrect.
- Upon review, the authors discovered that one of the figures (Fig. 5C) was assembled incorrectly.
- The corrected figure does not change the main conclusions of the study, and the authors expressed gratitude to the editor for allowing them to publish this correction while apologizing for any confusion caused.
The prodomain of bone morphogenetic protein 2 promotes dimerization and cleavage of BMP6 homodimers and BMP2/6 heterodimers.
J Biol Chem
October 2024
Department of Neurobiology, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah, USA; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. Electronic address:
Bone morphogenetic protein 2 (BMP2) and BMP6 are key regulators of systemic iron homeostasis. All BMPs are generated as inactive precursor proteins that dimerize and are cleaved to generate the bioactive ligand and inactive prodomain fragments, but nothing is known about how BMP2 or BMP6 homodimeric or heterodimeric precursor proteins are proteolytically activated. Here, we conducted in vitro cleavage assays, which revealed that BMP2 is sequentially cleaved by furin at two sites, initially at a site upstream of the mature ligand, and then at a site adjacent to the ligand domain, while BMP6 is cleaved at a single furin motif.
View Article and Find Full Text PDFLive-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer.
Cancer Res
November 2024
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
Article Synopsis
- * Researchers developed an experimental system to screen for signaling pathways during early 3D invasion in lung adenocarcinoma, revealing that loss of LKB1 enhances BMP6 signaling, which influences iron regulation and tumor growth.
- * In pre-clinical models, targeting the ALK2/BMP6 signaling pathway showed significant anti-tumor effects, and elevated BMP6 levels were found in lung cancer patients with LKB1 mutations, suggesting a potential treatment approach for these patients.
Reduced Plasma Bone Morphogenetic Protein 6 Levels in Sepsis and Septic Shock Patients.
Biomedicines
July 2024
Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Article Synopsis
- * Analysis of patients revealed that BMP6 levels were reduced in sepsis and septic shock compared to SIRS and healthy controls, showing no correlation with other inflammatory markers like procalcitonin and C-reactive protein.
- * Overall, the study concluded that normal BMP6 levels in SIRS are reduced in more severe infections, indicating that the increase in hepcidin and decrease in iron during these conditions are likely not linked to higher BMP6 levels.
The Influence of BMP6 on Serotonin and Glucose Metabolism.
Int J Mol Sci
July 2024
Laboratory for Mineralized Tissues, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Article Synopsis
- - The study investigates how bone morphogenetic protein 6 (BMP6) and serotonin (5HT) interact to regulate glucose metabolism, focusing on pancreatic β-cells using rat insulinoma cells and mouse models.
- - Findings indicate that BMP6 and 5HT have opposite effects on insulin secretion, and while BMP6 deletion in mice doesn't lead to diabetes, it causes subtle differences in insulin tolerance.
- - Ultimately, the research concludes that BMP6 does not have a direct impact on glucose metabolism, but its absence may lead to gradual changes in glucose and serotonin metabolism over time, especially as age progresses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!